These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27530617)
1. Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. Caille A; Kerry S; Tavernier E; Leyrat C; Eldridge S; Giraudeau B BMJ; 2016 Aug; 354():i4291. PubMed ID: 27530617 [No Abstract] [Full Text] [Related]
2. Bias in identifying and recruiting participants in cluster randomised trials: what can be done? Eldridge S; Kerry S; Torgerson DJ BMJ; 2009 Oct; 339():b4006. PubMed ID: 19819928 [No Abstract] [Full Text] [Related]
4. Cluster randomised trials in the medical literature: two bibliometric surveys. Bland JM BMC Med Res Methodol; 2004 Aug; 4():21. PubMed ID: 15310402 [TBL] [Abstract][Full Text] [Related]
5. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis. White IR; Thomas J Clin Trials; 2005; 2(2):141-51. PubMed ID: 16279136 [TBL] [Abstract][Full Text] [Related]
10. Allocation concealment in RCTs. El-Masri MM Can Nurse; 2014 Nov; 110(8):10. PubMed ID: 25536693 [No Abstract] [Full Text] [Related]
11. How well does blinding work in randomized controlled trials?: a counterpoint. Boehmer J; Yong P Clin Pharmacol Ther; 2009 May; 85(5):463-5. PubMed ID: 19381149 [No Abstract] [Full Text] [Related]
12. Evaluation of randomized controlled trials. Stanley K Circulation; 2007 Apr; 115(13):1819-22. PubMed ID: 17404173 [No Abstract] [Full Text] [Related]
14. Bias in recruitment to cluster randomized trials: a review of recent publications. Brierley G; Brabyn S; Torgerson D; Watson J J Eval Clin Pract; 2012 Aug; 18(4):878-86. PubMed ID: 21689213 [TBL] [Abstract][Full Text] [Related]
15. Issues in the planning and conduct of randomised trials. Bhandari M; Pape HC; Giannoudis PV Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524 [TBL] [Abstract][Full Text] [Related]
17. [STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE]. Ernest P; Jandrain B; Scheen AJ Rev Med Liege; 2015; 70(5-6):232-6. PubMed ID: 26285444 [TBL] [Abstract][Full Text] [Related]
18. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. Corbett MS; Higgins JP; Woolacott NF Res Synth Methods; 2014 Mar; 5(1):79-85. PubMed ID: 26054027 [TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trials in primary care: scope and application. Sheikh A; Smeeth L; Ashcroft R Br J Gen Pract; 2002 Sep; 52(482):746-51. PubMed ID: 12236280 [TBL] [Abstract][Full Text] [Related]